Mymee is a digital care platform that utilizes a proprietary method to identify individual triggers for autoimmune diseases and long COVID, enabling patients to correlate symptoms with specific factors in their environment. The program has demonstrated a mean reduction of over 40% in moderate to high-frequency symptoms, significantly improving patients' quality of life within an average of 17 weeks.
Funding
$25M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with autoimmune diseases and long COVID often struggle to identify the specific environmental and lifestyle factors that trigger their symptoms. This lack of clarity makes it difficult to manage flares and improve their overall quality of life. Current diagnostic methods often fail to capture the complex interplay between individual triggers and symptom exacerbation.
Solution
Mymee offers a digital care platform designed to identify individual triggers for autoimmune diseases and long COVID, enabling patients to correlate symptoms with specific factors in their environment. The platform combines a custom mobile app, a proprietary data platform, and weekly analysis sessions with a specialized health coach to provide personalized insights. By tracking symptoms and potential triggers, Mymee helps patients understand their unique sensitivities and make informed lifestyle adjustments. The program aims to reduce the frequency and severity of symptoms, leading to significant improvements in patients' well-being. Medication tapering support is provided based on genetics, personal preferences and health needs, in accordance with the physician and pharmacist-recommended drug regimen.
Target Audience
The primary target audience includes individuals diagnosed with autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, lupus, and multiple sclerosis, as well as those experiencing long COVID symptoms.
Features
- Personalized trigger identification through detailed tracking of symptoms, diet, and environmental factors
- Custom mobile app for logging daily experiences and monitoring symptom fluctuations
- Proprietary data platform that analyzes individual data to identify correlations between triggers and symptoms
- Weekly one-on-one sessions with a specialized health coach for personalized guidance and support
- Medication tapering support based on genetics, personal preferences and health needs, in accordance with the physician and pharmacist-recommended drug regimen.
- Integration of genetic data to personalize treatment plans
- HIPAA and SOC-2 compliance to ensure data privacy and security